Cancer clinical trials in the region Grand Est

245 currently recruiting clinical trials
Region Grand Est

Phase 2 Lymphoma #NCT06588478 #2024-515689-15-01
B cell lymphoma Lymphocytic lymphoma None None Systemic Treatment-Naive
Ghrmsa - Hôpital Emile Muller (Mulhouse)
Loxo Oncology
Phase 2 Liver and bile duct cancer #NCT04727307 #2024-519113-59-00
Hepatocellular carcinoma Localized Unhealthy A None Systemic Treatment-Naive
Surgery Transplant
CHRU de Nancy - Hôpitaux de Brabois (Vandœuvre-lès-Nancy)
CHU de Montpellier
Phase 2 CLL & Richter's syndrome #NCT05963074 #2023-504044-34-00
CLL (Chronic Lymphocytic Leukemia) None None Systemic Treatment-Naive
CHU Reims (Reims)
Janssen
Phase 2 CLL & Richter's syndrome #NCT06588478 #2024-515689-15-01
CLL (Chronic Lymphocytic Leukemia) 1 2 3 or more Targeted therapy
Systemic Treatment-Naive
Ghrmsa - Hôpital Emile Muller (Mulhouse)
Loxo Oncology
Phase 2 Lymphoma #NCT06588478 #2024-515689-15-01
B cell lymphoma Lymphocytic lymphoma None 1 2 3 or more Targeted therapy
Systemic Treatment-Naive
Ghrmsa - Hôpital Emile Muller (Mulhouse)
Loxo Oncology
Phase 2 CLL & Richter's syndrome #NCT06588478 #2024-515689-15-01
CLL (Chronic Lymphocytic Leukemia) None Systemic Treatment-Naive
Ghrmsa - Hôpital Emile Muller (Mulhouse)
Loxo Oncology
Phase 2 Colon cancer Rectal cancer #NCT06425133 #2023-509761-21-00
Adenocarcinoma Metastatic 1 2 3 or more Immunotherapy Chemotherapy Targeted therapy
Systemic Treatment-Naive
Hôpital Robert Schuman - UNEOS (Vantoux), Centre Hospitalier de Colmar (Colmar), ICANS - Institut de cancérologie Strasbourg Europe (Strasbourg), CHU Reims (Reims)
Centre Hospitalier Universitaire de Besancon
Phase 2 Kidney cancer #NCT05865730 #2024-516711-24-00
Clear cell carcinoma Locally Advanced Metastatic
ICANS - Institut de cancérologie Strasbourg Europe (Strasbourg)
EverImmune
Phase 2 Lung cancer #NCT05865730 #2024-516711-24-00
NSCLC (Non-Small Cell Lung Cancer) Non-squamous NSCLC Metastatic PDL1 Positive (>= 50%)
ICANS - Institut de cancérologie Strasbourg Europe (Strasbourg)
EverImmune